BriaCell Therapeutics Corp. BCTX
BCTX
BriaCell Therapeutics Corp. ALZN
Alzamend Neuro, Inc. BCTXW
BriaCell Therapeutics Corp. CNTX
Context Therapeutics Inc. DATS
DatChat, Inc. GRTX
Galera Therapeutics, Inc. MREO
Mereo BioPharma Group plc PDSB
PDS Biotechnology Corporation VRPX
Virpax Pharmaceuticals, Inc. XFOR
X4 Pharmaceuticals, Inc.
BriaCell Therapeutics Corp. ALZN
Alzamend Neuro, Inc. BCTXW
BriaCell Therapeutics Corp. CNTX
Context Therapeutics Inc. DATS
DatChat, Inc. GRTX
Galera Therapeutics, Inc. MREO
Mereo BioPharma Group plc PDSB
PDS Biotechnology Corporation VRPX
Virpax Pharmaceuticals, Inc. XFOR
X4 Pharmaceuticals, Inc.
Performance
| Periode | BCTX | ALZN | BCTXW | CNTX | DATS | GRTX | MREO | PDSB | VRPX | XFOR |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -74.24 % | -69.01 % | -22.48 % | 64.95 % | 19.59 % | -37.04 % | 5.26 % | -11.50 % | -91.92 % | -50.16 % |
| YTD | -87.03 % | -79.63 % | -79.09 % | 18.49 % | 45.88 % | -57.61 % | -41.52 % | -44.75 % | -99.78 % | -86.44 % |
| 1Y | -91.60 % | -85.45 % | -82.32 % | -29.15 % | 125.00 % | -75.00 % | -55.26 % | -70.86 % | -99.82 % | -81.72 % |
| 3Y | -98.86 % | -99.84 % | -98.03 % | 29.36 % | -71.90 % | -98.90 % | 100.02 % | -76.05 % | -99.99 % | -94.95 % |
| 5Y | 117 088.55 % | -99.99 % | -92.00 % | -72.35 % | -92.24 % | -99.86 % | -13.04 % | -59.33 % | -100.00 % | -98.49 % |
| 10Y | 64 763 507 772 333 687 015 437 802 405 888.00 % | -99.99 % | -92.00 % | -72.35 % | -92.24 % | -99.86 % | -69.23 % | -99.78 % | -100.00 % | -99.88 % |
| From the beginning | 1 728 177 641 553.91 % | -99.99 % | -92.00 % | -72.35 % | -92.24 % | -99.86 % | -69.23 % | -99.57 % | -100.00 % | -99.88 % |